Sofinnova Investments as of June 30, 2022
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 56 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 21.8 | $262M | 2.1M | 126.51 | |
| Natera (NTRA) | 9.2 | $110M | 3.1M | 35.44 | |
| Cincor Pharma | 8.7 | $105M | 5.6M | 18.84 | |
| Aerovate Therapeutics (AVTE) | 4.9 | $59M | 3.8M | 15.63 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 3.9 | $47M | 500k | 92.96 | |
| Vera Therapeutics Cl A (VERA) | 3.6 | $43M | 3.2M | 13.61 | |
| Health Care Select Sector SPDR Fund Sib Healthcare Put Option (XLV) | 3.2 | $39M | 300k | 128.24 | |
| Y Mabs Therapeutics (YMAB) | 2.8 | $33M | 2.2M | 15.13 | |
| Merck & Co (MRK) | 2.7 | $33M | 361k | 91.17 | |
| Novo-Nordisk A S Adr (NVO) | 2.5 | $31M | 274k | 111.43 | |
| SPDR S&P Biotech ETF S&p Biotech Put Option (XBI) | 2.5 | $30M | 400k | 74.27 | |
| United Therapeutics Corporation (UTHR) | 2.1 | $25M | 106k | 235.64 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $25M | 302k | 82.87 | |
| Reata Pharmaceuticals Cl A | 2.0 | $24M | 784k | 30.39 | |
| Chemocentryx Call Option | 1.8 | $22M | 887k | 24.78 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $21M | 75k | 281.79 | |
| AstraZeneca Sponsored Adr (AZN) | 1.7 | $21M | 316k | 66.07 | |
| Regenxbio Inc equity us cm (RGNX) | 1.6 | $19M | 777k | 24.70 | |
| Inozyme Pharma (INZY) | 1.5 | $17M | 3.7M | 4.77 | |
| Cti Biopharma | 1.3 | $16M | 2.7M | 5.97 | |
| Irhythm Technologies (IRTC) | 1.3 | $15M | 142k | 108.03 | |
| Sanofi SA Sponsored Adr (SNY) | 1.2 | $14M | 282k | 50.03 | |
| Dex (DXCM) | 1.2 | $14M | 189k | 74.53 | |
| Cytokinetics (CYTK) | 1.0 | $13M | 321k | 39.29 | |
| Nextcure (NXTC) | 1.0 | $13M | 2.7M | 4.70 | |
| Immatics NV SHS (IMTX) | 0.9 | $11M | 1.3M | 8.71 | |
| Prometheus Biosciences | 0.9 | $11M | 386k | 28.23 | |
| Sarepta Therapeutics (SRPT) | 0.8 | $9.8M | 131k | 74.96 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.8 | $9.2M | 328k | 28.10 | |
| Horizon Therapeutics SHS | 0.7 | $8.0M | 100k | 79.76 | |
| Syndax Pharmaceuticals (SNDX) | 0.7 | $8.0M | 413k | 19.24 | |
| Obseva Sa | 0.6 | $7.6M | 4.7M | 1.61 | |
| Adicet Bio (ACET) | 0.6 | $7.6M | 518k | 14.60 | |
| Akouos | 0.6 | $7.1M | 1.5M | 4.69 | |
| Iveric Bio | 0.5 | $6.3M | 653k | 9.62 | |
| Geron Corporation (GERN) | 0.5 | $5.9M | 3.8M | 1.55 | |
| argenx SE Sponsored Adr (ARGX) | 0.5 | $5.7M | 15k | 378.87 | |
| Bolt Biotherapeutics (BOLT) | 0.5 | $5.6M | 2.8M | 2.04 | |
| Travere Therapeutics (TVTX) | 0.4 | $5.2M | 213k | 24.23 | |
| ImmunoGen | 0.4 | $5.1M | 1.1M | 4.50 | |
| Seagen | 0.4 | $4.9M | 28k | 176.96 | |
| Chinook Therapeutics | 0.4 | $4.8M | 277k | 17.49 | |
| Xencor (XNCR) | 0.4 | $4.3M | 158k | 27.37 | |
| Nucana Biomed Sponsored Adr (NCNA) | 0.3 | $4.1M | 5.6M | 0.72 | |
| Galera Therapeutics (GRTX) | 0.3 | $4.0M | 3.1M | 1.30 | |
| Amylyx Pharmaceuticals (AMLX) | 0.3 | $3.6M | 187k | 19.26 | |
| Jounce Therapeutics | 0.2 | $3.0M | 982k | 3.03 | |
| Agenus (AGEN) | 0.2 | $1.8M | 953k | 1.94 | |
| Nucana Biomed Ordinary Shares | 0.1 | $1.7M | 2.4M | 0.72 | |
| Inhibrx (INBX) | 0.1 | $1.7M | 148k | 11.35 | |
| Celldex Therapeutics (CLDX) | 0.1 | $1.3M | 48k | 26.95 | |
| Protagonist Therapeutics Call Option (PTGX) | 0.1 | $791k | 100k | 7.91 | |
| Synlogic | 0.1 | $661k | 575k | 1.15 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $521k | 143k | 3.65 | |
| Fusion Pharmaceuticals (FUSN) | 0.0 | $194k | 78k | 2.49 | |
| Insmed Com Par $.01 (INSM) | 0.0 | $145k | 7.4k | 19.67 |
